Back to Search Start Over

S132 An Interim Analysis of a Phase 3, Open-Label Study Indicates Efficacy and Safety of RBX2660 in Patients With Recurrent Clostridioides difficile Infection

Authors :
Sahil Khanna
Erik R. Dubberke
Whitfield L. Knapple
Paul Feuerstadt
Maha Assi
Samson Ng
Beth Guthmueller
Source :
American Journal of Gastroenterology. 117:e96-e96
Publication Year :
2022
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2022.

Subjects

Subjects :
Hepatology
Gastroenterology

Details

ISSN :
15720241 and 00029270
Volume :
117
Database :
OpenAIRE
Journal :
American Journal of Gastroenterology
Accession number :
edsair.doi...........626f239d67e77e538855c76305ba1b35

Tools

Authors Abstract Subjects Details